Rhythm Management Group Launches RhythmSynergy™ Technology Platform

Rhythm Management Group, PLLC, has completed the launch of RhythmSynergy™, a powerful new technology platform that leverages machine-learning to efficiently deliver timely and relevant clinical insights for remotely monitored patients with implantable cardiac devices and wearable devices such as blood pressure cuffs, scales, and glucometers.

Recognized as one of the fastest growing companies in North America, Rhythm has more than a decade of experience centralizing and streamlining remote monitoring operational workflows for medical practices and health systems. It applied that knowledge to RhythmSynergy, focusing on features that enhance efficiency such as automated image processing and intuitive reporting.

“With over 10 years in the remote monitoring space and more than 100 years of combined clinical experience, we understand what staff and clinicians need from their remotely monitored data,” said Rhonda Bray, RN, Founder and CEO, Rhythm Management Group. “By extracting that information and providing clinically validated alerts, we accelerate risk identification so users of RhythmSynergy can provide more timely care.”

Key features of RhythmSynergy include:

  • Intuitive clinical and operational reporting
  • Automated image processing
  • Bi-directional EHR integration
  • Mobile and desktop optimized
  • Compliance with industry-leading security standards
  • Secure and scalable infrastructure

By combining clinical expertise and machine-learning technology, RhythmSynergy prioritizes critical information and streamlines review processes. Its sleek, secure design and powerful reporting tools make it easy to review, share, and analyze patient data. By employing automated data processing and real-time alerts, RhythmSynergy enables faster identification of patient health problems so physicians can intervene sooner.

Dr. John P. McKenzie, of Heartbeat Cardiovascular Medical Group, of Glendale, CA, a Rhythm customer, said, “Rhythm’s remote monitoring program, experienced clinical and engagement teams, and RhythmSynergy platform help us deliver better outcomes for patients without burdening our staff. The platform provides the data we need to make critical, informed care decisions, and optimizes data management by helping us achieve 90 percent remote monitoring penetration.”

The RhythmSynergy platform is available for both types of remote monitoring provided by Rhythm Management Group: Cardiac Rhythm Management (CRM) Monitoring, which is for patients with implantable cardiac devices, and Remote Physiologic Monitoring (RPM), which is for patients with smart health tech wireless devices like blood pressure cuffs, scales, and glucometers.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.